Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Vasiliki Michalarea, MD, Dima El-Sharkawi, MBBS BSc FRCPath MD, Siraj Yusuf, Mary Gleeson, Laura Hickmott, Andrew Wotherspoon, Ayoma Attygalle, Simon O'Connor, Bhupinder Sharma, Yong Du, Imene Zerizer, Alan Horwich, Gillian Ross, Andrea Kuhnl, Sunil Iyengar, Ian Chau, MD, David Cunningham

Blood (2018) 132 (Supplement 1): 4240.

https://doi.org/10.1182/blood-2018-99-119560

Published: 2018

Journal Articles

Thymic Hyperplasia after Chemotherapy: Combined Experience of Two Centers

Pamela Dominguez-Perez, MD, Nicole Maxey, MD, Zeinab Mohammadi, MD, Erasto Cortes, MD, Nishaal Antony, MD, Anuradha Gupta, MD, Mark M Landeros, MD, Angel Campos-Gines, MD, Ethan Reiter, Carmen Arango, MD, Javier Gutierrez, MD, Elena Morales, MD, Matilde Gonzalez, MD, Juan Herrada, MD

Blood (2015) 126 (23): 4633.

https://doi.org/10.1182/blood.V126.23.4633.4633

Published: 2015

Journal Articles

JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model

Degryse Sandrine, Charles E de Bock, PhD, Carmen Vicente, PhD, Luk Cox, PhD, Olga Gielen, Nicole Mentens, Kris Jacobs, Ellen Geerdens, Thomas Tousseyn, PhD, Jan Cools, PhD

Blood (2014) 124 (21): 361.

https://doi.org/10.1182/blood.V124.21.361.361

Published: 2014

Journal Articles

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

Toshihiro Fujiki, MD, Hideaki Maeba, MD, Raita Araki, MD, Yasuhiro Ikawa, MD PhD, Rie Kuroda, MD, Shintaro Mase, MD, Masaki Fukuda, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD

Blood (2014) 124 (21): 5409.

https://doi.org/10.1182/blood.V124.21.5409.5409

Published: 2014

Journal Articles

A Novel Synthetic GMCSF and IL7 Fusion Cytokine (GIFT7) Leads to T Cell Neogenesis by Reversing Age-Related Thymic Atrophy and Overcoming PD-1-Assocaited CD8 Exhaustion

Jeremy Hsieh, Colleen McGary, JianHui Wu, PhD, Mirko Paiardini, PhD, Luca Micci, Anapatricia Garcia, DVM, PhD, Guido Silvestri, MD, PhD, Mohammad Sohrab Hossain, Ph.D, Edmund K. Waller, MD, PhD, Jacques Galipeau, MD

Blood (2012) 120 (21): 3289.

https://doi.org/10.1182/blood.V120.21.3289.3289

Published: 2012

Journal Articles

Six Cycles of ABVD and a Negative PET Scan Negates the Need for Radiologic Follow-up in Early Stage, Non-Bulky Hodgkin Lymphoma: MSKCC Retrospective Analysis

Sidonie K Hartridge-Lambert, MBBS, Heiko Schoder, MD, Remy C Lim, MD, Jocelyn C Maragulia, Carol S Portlock, MD

Blood (2011) 118 (21): 3139.

https://doi.org/10.1182/blood.V118.21.3139.3139

Published: 2011

NARROW

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Thymic Hyperplasia after Chemotherapy: Combined Experience of Two Centers

JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

A Novel Synthetic GMCSF and IL7 Fusion Cytokine (GIFT7) Leads to T Cell Neogenesis by Reversing Age-Related Thymic Atrophy and Overcoming PD-1-Assocaited CD8 Exhaustion

Six Cycles of ABVD and a Negative PET Scan Negates the Need for Radiologic Follow-up in Early Stage, Non-Bulky Hodgkin Lymphoma: MSKCC Retrospective Analysis

Email alerts

ASH Publications

American Society of Hematology

Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Thymic Hyperplasia after Chemotherapy: Combined Experience of Two Centers

JAK3 Mutants Transform Hematopoietic Cells through JAK1 Activation Causing T-Cell Acute Lymphoblastic Leukemia in a Bone Marrow Transplant Mouse Model

Thymic 18 F-FDG PET/CT Findings in Pediatric Malignant Lymphoma after Chemotherapy: Differentiation of Long-Lasting Thymic Hyperplasia from Lymphoma Recurrence

A Novel Synthetic GMCSF and IL7 Fusion Cytokine (GIFT7) Leads to T Cell Neogenesis by Reversing Age-Related Thymic Atrophy and Overcoming PD-1-Assocaited CD8 Exhaustion

Six Cycles of ABVD and a Negative PET Scan Negates the Need for Radiologic Follow-up in Early Stage, Non-Bulky Hodgkin Lymphoma: MSKCC Retrospective Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only